Bank of Montreal
TARA icon

Bank of Montreal’s Protara Therapeutics TARA Stock Holding History

Bank of Montreal’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-61,742
Closed -$954K – 4830
2021
Q1 		$954K Buy
61,742
+61,130
+9,989% +$1.13M ﹤0.01% 2221
2020
Q4 		$13K Buy
612
+518
+551% +$11.2K ﹤0.01% 4594
2020
Q3 		$2K Sell
94
-76
-45% -$1.76K ﹤0.01% 4649
2020
Q2 		$5K Buy
+170
New +$5.26K ﹤0.01% 4422

Other funds holding TARA

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bank of Montreal's TARA Position: Q2 2021 in Review

Bank of Montreal sold out of Protara Therapeutics (TARA) in Q2 2021, closing a stake of 61,742 shares — an estimated $954K sold.

Bank of Montreal first reported a position in TARA in Q2 2020 and held it in 4 quarters. The position peaked at $954K in Q1 2021. 41 funds tracked by Wall St. Rank hold TARA as of Q2 2021.

  • Bank of Montreal reported no remaining Protara Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 61,742 Protara Therapeutics shares in Q2 2021, an estimated $954K.
  • Bank of Montreal first reported a position in Protara Therapeutics in Q2 2020 and held it in 4 quarters.
  • Bank of Montreal's Protara Therapeutics position peaked at $954K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.